Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1898488

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1898488

Topical Pain Relief Market Size, Share, and Growth Analysis, By Therapeutic Classes (Non-opioids, Opioids), By Formulation (Cream, Gel), By Gender, By Age Group, By Type, By Distribution Channel, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Topical Pain Relief Market size was valued at USD 12.02 Billion in 2024 and is poised to grow from USD 12.9 Billion in 2025 to USD 22.66 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The growing prevalence of arthritis significantly drives revenue growth in the global topical pain relief market. Additionally, the increasing elderly population and high demand among athletes contribute to this expansion. The market is characterized by a thorough analysis of segments, trends, drivers, and competitive dynamics. Factors such as rising cases of diabetic neuropathy and cancer-related pain further enhance market opportunities. The shift toward topical solutions is favored due to their reduced side effects compared to oral medications. Nonetheless, challenges like potential skin irritation and unpleasant odors can hinder growth. In contrast, the rise of online platforms and emerging markets present exciting avenues for expansion, highlighting the intricate balance of challenges and opportunities shaping the topical pain relief landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The growing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, significantly fuels the demand for topical pain relief options. Individuals are increasingly looking for effective localized pain management solutions that provide both convenience and focused alleviation. This trend reflects a shift in consumer preferences towards therapies that can be easily applied to specific areas of discomfort, enhancing the overall efficacy of pain relief strategies. As awareness of these conditions rises, the market for topical pain relief products continues to expand, catering to the evolving needs of those seeking immediate and accessible solutions for pain alleviation.

Restraints in the Global Topical Pain Relief Market

The global market for topical pain relief products faces a significant challenge stemming from the lack of comprehensive clinical evidence that substantiates their efficacy and safety. This deficiency can undermine consumer confidence and impede widespread adoption, as potential users may be hesitant to rely on these products without substantiated proof from rigorous studies. Consequently, the uncertainty regarding the effectiveness and safety profiles of topical pain relief options can limit their acceptance among both consumers and healthcare providers, presenting a notable restraint in the growth and expansion of this market segment. Addressing this gap is crucial for fostering trust and enhancing product uptake.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the incorporation of natural and herbal ingredients, reflecting a growing consumer preference for products that emphasize health and wellness. As awareness of synthetic alternatives diminishes, individuals are gravitating towards formulations that harness the power of botanicals, known for their analgesic and anti-inflammatory properties. This shift is driven by a desire for safer, less chemically laden options, prompting manufacturers to innovate and expand their product lines. Consequently, the market is evolving, with an increasing emphasis on transparency, ingredient sourcing, and sustainability, aligning with broader consumer wellness trends.

Product Code: SQMIG35I2258

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer And Buying Criteria Analysis
  • Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2026-2033)

  • Market Overview
  • Non-opioids
    • Nonsteroidal anti-inflammatory drug (NSAIDS)
    • Methyl salicylates
    • Capsaicin
    • Lidocaine
    • Other non-opioids
  • Opioids
    • Buprenorphine
    • Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2026-2033)

  • Market Overview
  • Cream
  • Gel
  • Spray
  • Patch
  • Others

Global Topical Pain Relief Market Size by Gender & CAGR (2026-2033)

  • Market Overview
  • Women
  • Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2026-2033)

  • Market Overview
  • Adults (18-64 Years)
  • Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Prescription Pain Relief
  • Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Pharmacy and Drug Stores
  • Retail Stores
  • Online Stores

Global Topical Pain Relief Market Size & CAGR (2026-2033)

  • North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • US
    • Canada
  • Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Endo International plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mylan N.V. (now part of Viatris Inc.) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AdvaCare Pharma (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Topical Biomedics Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!